Price Kevin 4
4 · PHARMATHENE, INC · Filed Feb 10, 2009
Insider Transaction Report
Form 4
Price Kevin
President - PharmAthene UK,Ltd
Transactions
- Award
Stock Option (right to buy)
2009-01-21+1,900→ 166,900 totalExercise: $2.46Exp: 2019-01-21→ Common Stock (1,900 underlying)
Footnotes (2)
- [F1]The option vests over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.
- [F2]On January 21, 2009, the date such stock options were granted, the closing price of the Issuer's common stock was $2.46 per share.